| |
| |
|
| Insider
Information: |
Kingsley Alfred D |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,968,356 |
|
|
Indirect Shares
|
1,512,809 |
|
|
| Direct
Value |
$5,137,134 |
|
|
|
Indirect Value
|
$1,323,637 |
|
|
| Total
Shares |
7,481,165 |
|
|
| Total
Value |
$6,460,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
3.0
|
| Percentage
Gain/Loss : |
 -38.5%
|
 148.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-22 |
5,470,245 |
2021-06-22 |
1,418,697 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-06-09 |
9,000 |
2015-06-25 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
489,111 |
2023-06-23 |
94,112 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCX |
Oncocyte Corp |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
296,902 |
|
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
94,112 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-20 |
4 |
B |
$0.24 |
$11 |
D/D |
45 |
4,569,522 |
2.36 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-22 |
4 |
B |
$0.24 |
$17 |
D/D |
72 |
4,569,522 |
2.36 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-08-18 |
4 |
A |
$0.20 |
$20 |
D/D |
100 |
4,579,677 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-08-14 |
4 |
A |
$0.20 |
$60 |
D/D |
300 |
4,573,822 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-08 |
4 |
B |
$0.24 |
$76 |
D/D |
315 |
4,516,719 |
2.36 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-08-21 |
4 |
A |
$0.20 |
$67 |
D/D |
333 |
4,580,010 |
|
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-23 |
4 |
S |
$2.55 |
$2,295 |
D/D |
(900) |
318,840 |
0 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-23 |
4 |
B |
$0.24 |
$276 |
D/D |
1,150 |
4,569,522 |
2.36 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-23 |
4 |
OE |
$1.34 |
$1,658 |
D/D |
1,237 |
319,740 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-14 |
4 |
B |
$0.24 |
$576 |
D/D |
2,400 |
4,516,719 |
2.36 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,715 |
2,079,413 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,429 |
2,082,842 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-08-11 |
4 |
A |
$0.20 |
$800 |
D/D |
4,000 |
4,573,522 |
|
- |
|
| AST |
Asterias Biotherapeutics ... |
Director |
– • – |
2016-06-09 |
4 |
B |
$2.93 |
$11,720 |
D/D |
4,000 |
9,000 |
2.39 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-13 |
4 |
B |
$0.24 |
$1,196 |
D/D |
4,982 |
4,516,719 |
2.36 |
- |
|
| AST |
Asterias Biotherapeutics ... |
Director |
– • – |
2015-06-25 |
4 |
B |
$4.32 |
$21,577 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-06-15 |
4 |
B |
$0.24 |
$1,320 |
D/D |
5,500 |
4,516,719 |
2.36 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-08-15 |
4 |
A |
$0.20 |
$1,151 |
D/D |
5,755 |
4,579,577 |
|
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,909 |
302,811 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,390 |
5,457,945 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
7,000 |
414,184 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-22 |
4 |
S |
$0.00 |
$0 |
D/D |
(7,652) |
318,503 |
0 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,572 |
4,786,765 |
0 |
- |
|
84 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
